Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma

Saved in:
Bibliographic Details
Main Authors: Eun Seop Seo, In Hwa Jeong, Hee Young Ju, Ju Kyung Hyun, Ji Won Lee, Keon Hee Yoo, Won Young Heo, Ki Woong Sung, Hee Won Cho, Eun-Suk Kang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1565304/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832541062088884224
author Eun Seop Seo
Eun Seop Seo
In Hwa Jeong
In Hwa Jeong
Hee Young Ju
Ju Kyung Hyun
Ji Won Lee
Keon Hee Yoo
Won Young Heo
Ki Woong Sung
Hee Won Cho
Eun-Suk Kang
author_facet Eun Seop Seo
Eun Seop Seo
In Hwa Jeong
In Hwa Jeong
Hee Young Ju
Ju Kyung Hyun
Ji Won Lee
Keon Hee Yoo
Won Young Heo
Ki Woong Sung
Hee Won Cho
Eun-Suk Kang
author_sort Eun Seop Seo
collection DOAJ
format Article
id doaj-art-319f521760d84928b2048b60517a6d65
institution Kabale University
issn 1664-3224
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-319f521760d84928b2048b60517a6d652025-02-04T09:48:05ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-02-011610.3389/fimmu.2025.15653041565304Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastomaEun Seop Seo0Eun Seop Seo1In Hwa Jeong2In Hwa Jeong3Hee Young Ju4Ju Kyung Hyun5Ji Won Lee6Keon Hee Yoo7Won Young Heo8Ki Woong Sung9Hee Won Cho10Eun-Suk Kang11Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Digital Health, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of KoreaDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Laboratory Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Republic of KoreaDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Koreahttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1565304/fullneuroblastomaPIRCHEhaploidentical hematopoietic stem cell transplantationrelapse/refractoryHLA mismatch
spellingShingle Eun Seop Seo
Eun Seop Seo
In Hwa Jeong
In Hwa Jeong
Hee Young Ju
Ju Kyung Hyun
Ji Won Lee
Keon Hee Yoo
Won Young Heo
Ki Woong Sung
Hee Won Cho
Eun-Suk Kang
Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
Frontiers in Immunology
neuroblastoma
PIRCHE
haploidentical hematopoietic stem cell transplantation
relapse/refractory
HLA mismatch
title Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
title_full Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
title_fullStr Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
title_full_unstemmed Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
title_short Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
title_sort corrigendum predicted indirectly recognizable hla epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
topic neuroblastoma
PIRCHE
haploidentical hematopoietic stem cell transplantation
relapse/refractory
HLA mismatch
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1565304/full
work_keys_str_mv AT eunseopseo corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT eunseopseo corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT inhwajeong corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT inhwajeong corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT heeyoungju corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT jukyunghyun corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT jiwonlee corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT keonheeyoo corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT wonyoungheo corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT kiwoongsung corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT heewoncho corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma
AT eunsukkang corrigendumpredictedindirectlyrecognizablehlaepitopesscoresandclinicaloutcomesafterhaploidenticalstemcelltransplantationinpediatricpatientswithrelapsedneuroblastoma